# Telix Pharmaceuticals Ltd: Form 6-K, filed Sep 30, 2026

- Company: [Telix Pharmaceuticals Ltd](/companies/tlx.md) (CIK 2007191)
- Form: 6-K
- Filed: 2026-09-30
- Accepted by EDGAR: Sep 29, 2026, 20:19 ET
- Period: 2026-09-30
- Accession: 0001628280-26-063875
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2007191/000162828026063875/telix-6kbipassgainsfdafast.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007191/000162828026063875/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007191/000162828026063875/telix-6kbipassgainsfdafast.htm

Filed Sep 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-063875. Last ingested by Listed: Oct 29, 2026, 16:54 ET. No prices; not investment advice.